Source Date: pubinfo_daily_2021_10_15_1122_Fri

Bill: AB 789

"This Bill Would"s:

Bill Text:



20210AB__078999INT99INTRODUCED2021-02-1620210AB789INTIntroduced by Assembly Members Low and Gipson(Coauthor: Assembly Member Chiu)LEAD_AUTHORASSEMBLYLowLEAD_AUTHORASSEMBLYGipsonCOAUTHORASSEMBLYChiu An act to add Section 1316.7 to the Health and Safety Code, relating to health facilities. health facilitiesHealth care facilities.

Existing law provides for the licensure and regulation of health facilities and clinics, including primary care clinics, by the State Department of Public Health. A violation of these provisions is a crime.

This bill would require a primary care services in an outpatient department of a health facility or a primary care clinic, as specified, to offer a patient receiving health services a hepatitis B screening test and a hepatitis C screening test, as specified. The bill would also require the practitioner to offer the patient followup health care or refer the patient to a health care provider who can provide followup health care if the screening test is positive or reactive, as specified.

By expanding the definition of a crime, this bill would impose a state-mandated local program.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason.

MAJORITYNOYESYESNONONONONONONO
The people of the State of California do enact as follows:SECTION 1.Section 1316.7 is added to the Health and Safety Code, to read:1316.7.

(a)A patient who receives primary care services in an outpatient department of a health facility or receives primary care from a primary care clinic, as specified by subdivision (a) of Section 1204, shall be offered a hepatitis B screening test and a hepatitis C screening test according to the latest recommendations from the United States Preventive Services Task Force, unless the practitioner reasonably believes that one of the following conditions applies:

(1)The patient is being treated for a life-threatening emergency.

(2)(A)The patient has previously been offered or has been the subject of a hepatitis B or C screening test.

(B)This paragraph does not apply if the practitioner determines that the one or both of the tests should be offered again.

(3)The patient lacks capacity to consent to a hepatitis B or hepatitis C screening test, or both.

(b)(1)If a patient accepts the offer of the hepatitis B screening test and the test is hepatitis B surface antigen (HBsAg) positive, the health care provider shall offer the patient followup health care or refer the patient to a health care provider who can provide followup health care.

(2)If a patient accepts the offer of the hepatitis C screening test and the test is reactive, the health care provider shall offer the patient followup health care or refer the patient to a health care provider who can provide followup health care. The followup health care shall include a hepatitis C diagnostic test (HCV RNA).

(c)The offering of hepatitis B and hepatitis C screening testing under this section shall be culturally and linguistically appropriate.

(d)This section shall not affect the scope of practice of any health care practitioner or diminish any authority or legal or professional obligation of any health care practitioner to offer a hepatitis B or hepatitis C screening test, or both, or hepatitis B or hepatitis C diagnostic test, or both, or to provide services or care for the subject of a hepatitis B or hepatitis C screening test, or both, or hepatitis B or hepatitis C diagnostic test, or both.

(e)For purposes of this section, the following definitions apply:

(1)?Hepatitis B screening test? includes any laboratory tests or tests that detect the presence of hepatitis B surface antigen (HBsAg) and provides confirmation of whether the patient has a chronic hepatitis B infection.

(2)?Hepatitis C screening test? includes any laboratory screening test or tests that detect the presence of hepatitis C virus antibodies in the blood and provides confirmation of whether the patient has ever been infected with the hepatitis C virus.

(3)?Hepatitis C diagnostic test? includes any laboratory test or tests that detect the presence of the hepatitis C virus in the blood and provides confirmation of whether the patient has an active hepatitis C virus infection.

SEC. 2.

No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.